EUR 3.13
(-1.57%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.76 Million EUR | -17.43% |
2022 | 3.34 Million EUR | -2.16% |
2021 | 3.42 Million EUR | 552.14% |
2020 | 524.76 Thousand EUR | 0.0% |
2019 | - EUR | 0.0% |
2018 | - EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 FY | 2.76 Million EUR | -17.43% |
2023 Q2 | - EUR | -100.0% |
2022 Q4 | 3.34 Million EUR | 1327.14% |
2022 Q2 | 234.61 Thousand EUR | -93.14% |
2022 FY | 3.34 Million EUR | -2.16% |
2021 Q4 | 3.42 Million EUR | 1226.05% |
2021 FY | 3.42 Million EUR | 552.14% |
2021 Q2 | 258.07 Thousand EUR | -50.82% |
2020 Q2 | 0.51 EUR | 0.0% |
2020 Q4 | 524.76 Thousand EUR | 102894605.93% |
2020 FY | 524.76 Thousand EUR | 0.0% |
2019 FY | - EUR | 0.0% |
2018 FY | - EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
MPH Health Care AG | - EUR | -Infinity% |
Apontis Pharma AG | 6.6 Million EUR | 58.112% |
Dermapharm Holding SE | 320.75 Million EUR | 99.138% |
Evotec SE | 30.89 Million EUR | 91.05% |
MERCK Kommanditgesellschaft auf Aktien | 4.63 Billion EUR | 99.94% |
PharmaSGP Holding SE | 10.11 Million EUR | 72.674% |